Old Web
English
Sign In
Acemap
>
Paper
>
Complete Response of Primary Refractory ALK+ Large B-cell Lymphoma treated with Single Agent Nivolumab
Complete Response of Primary Refractory ALK+ Large B-cell Lymphoma treated with Single Agent Nivolumab
2019
Jose Sandoval-Sus
Amanda Brahim
Alina Khan
Yehuda E. Deutsch
Barbara Raphael
Ali Ansari-Lari
Hugo F. Fernandez
Luis E. Raez
Keywords:
Cancer research
Nivolumab
B-cell lymphoma
Refractory
Pathology
Medicine
ALK positive large B-cell lymphoma
Immunotherapy
single agent
immune checkpoint inhibitors
Immunology
T-cell lymphoma
complete response
Correction
Source
Cite
Save
Machine Reading By IdeaReader
25
References
1
Citations
NaN
KQI
[]